-
Notifications
You must be signed in to change notification settings - Fork 26
Commit
This commit does not belong to any branch on this repository, and may belong to a fork outside of the repository.
Merge pull request #4276 from ebmdatalab/amend_measure__trimipramine
Update lptrimipramine.json
- Loading branch information
Showing
1 changed file
with
26 additions
and
12 deletions.
There are no files selected for viewing
This file contains bidirectional Unicode text that may be interpreted or compiled differently than what appears below. To review, open the file in an editor that reveals hidden Unicode characters.
Learn more about bidirectional Unicode characters
Original file line number | Diff line number | Diff line change |
---|---|---|
@@ -1,17 +1,23 @@ | ||
{ | ||
"name": "NHS England Low Priority Treatment - trimipramine", | ||
"title": [ | ||
"Trimipramine cost per 1000 patients" | ||
], | ||
"description": [ | ||
"Cost of trimipramine per 1000 patients" | ||
], | ||
"name": "Items which should not routinely be prescribed in primary care - trimipramine", | ||
"title": "Trimipramine cost per 1000 patients", | ||
"description": "Cost of trimipramine per 1000 patients", | ||
"numerator_short": "Trimipramine cost (£)", | ||
"denominator_short": "1000 patients", | ||
"why_it_matters": [ | ||
"Trimipramine is an older tricyclic antidepressant. The cost has increased significantly recently, ", | ||
"and there are newer, cheaper alternatives are available, which are ", | ||
"<a href='https://www.nice.org.uk/Guidance/CG90'> recommended by NICE in preference to tricyclic antidepressants</a>. " | ||
"<p><a href='https://www.england.nhs.uk/long-read/items-which-should-not-routinely-be-prescribed-in-primary-care-policy-guidance/#trimipramine-2017' target='_Blank'>", | ||
"NHS England guidance states</a>:</p>", | ||
"<i><p>The tricyclic antidepressant (TCA) trimipramine is significantly more expensive than other antidepressants.</p>", | ||
"<p>NICE guidance on depression in adults recommends selective serotonin reuptake inhibitor (SSRI) antidepressants first line if indicated as they have a more favourable risk-to-benefit ratio ", | ||
"compared to TCAs. However, if a TCA is required, more cost-effective TCAs than trimipramine are available.</p>", | ||
"<p>Due to the significant cost associated with trimipramine and the availability of alternative treatments, the joint clinical working group considered trimipramine suitable for inclusion in this guidance.</p></i>", | ||
"<p>NHS England recommend that GPs:", | ||
"<ul>", | ||
"<li>Do not initiate.</li>", | ||
"<li>Deprescribe in patients currently prescribed this medicine.</li>", | ||
"<li>Prescribe only if no other item or intervention is clinically appropriate.</li>", | ||
"<li>Prescribe only if no other item or intervention is available.</li>", | ||
"</ul>" | ||
], | ||
"tags": [ | ||
"cost", | ||
|
@@ -27,5 +33,13 @@ | |
"numerator_bnf_codes_filter": [ | ||
"0403010Y0 # Trimipramine Maleate" | ||
], | ||
"denominator_type": "list_size" | ||
} | ||
"denominator_type": "list_size", | ||
"authored_by": "[email protected]", | ||
"checked_by": "[email protected]", | ||
"date_reviewed": "2023-08-15", | ||
"next_review": "2025-08-15", | ||
"measure_complexity": "low", | ||
"measure_type": "bnf_code", | ||
"radar_exclude": false | ||
|
||
} |